Lineage Cell Therapeutics, Inc. Common Stock (LCTX)
Gross Profit Growth
-67.64%
Quarterly · Period ending:
LCTX Gross Profit Growth
Year-over-year change vs the same period a year earlier
Latest reported-67.64%period ending
Latest reported-67.64%period ending
LCTX Quarterly Gross Profit YoY % (0.00% → -67.64%)
Year-over-year change
High-resolution chart · PNG
LCTX gross profit growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Gross Profit Growth |
|---|---|
| 61.673% | |
| 79.1016% | |
| 91.5173% | |
| -80.652% | |
| -96.9117% | |
| -95.4363% | |
| 0% | |
| 50% | |
| 300% | |
| 0% | |
| 0% | |
| 400% | |
| 0% | |
| 0% | |
| 0% | |
| 200% | |
| 0% | |
| 0% | |
| -200% | |
| 0% | |
| 200% | |
| 200% | |
| 100% | |
| 0% | |
| 0% |